Vascepa Alternatives Compared
| Vascepa (icosapent) | Semaglutide | Wegovy (semaglutide) |
|
|---|
| Vascepa (icosapent) | Semaglutide | Wegovy (semaglutide) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Vascepa is a prescription, high-purity eicosapentaenoic acid (EPA - a type of omega-3 fatty acid), that may be used to lower the risk of cardiovascular disease in people with high triglyceride levels... View more |
Prescription only
Semaglutide (Ozempic, Rybelsus) lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the... View more |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Cardiovascular Risk Reduction, Nonalcoholic Steatohepatitis. Wegovy may also be used for purposes not listed in this medication guide. |
Related suggestions Cardiovascular Risk Reduction
Popular comparisons
|
|||||||
| More about Vascepa (icosapent) | More about Semaglutide | More about Wegovy (semaglutide) | ||||||||
| Ratings & Reviews | ||||||||||
|
Vascepa has an average rating of 5.7 out of 10 from a total of 119 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 40% reported a negative effect. |
Semaglutide has an average rating of 6.9 out of 10 from a total of 2769 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 20% reported a negative effect. |
Wegovy has an average rating of 7.6 out of 10 from a total of 527 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 15% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Vascepa side effects |
View all Semaglutide side effects |
View all Wegovy side effects |
||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
View all Vascepa prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
|
||||||||
| Brand Names | ||||||||||
|
N/A |
Ozempic, Rybelsus, Wegovy | Other semaglutide brands include: Ozempic, Rybelsus | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
89 hours |
168 hours |
168 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 76 drugs are known to interact with Vascepa:
|
A total of 275 drugs are known to interact with Semaglutide:
|
A total of 275 drugs are known to interact with Wegovy:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
July 26, 2012 |
December 05, 2017 |
N/A |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.